Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
PHOSPHOCOL P32 is a radioactive chromic phosphate injection used for intracavitary therapy, primarily in oncology for palliative treatment and reduction of effusions. It is a radiopharmaceutical that localizes to specific tissue sites and delivers therapeutic radiation. The mechanism relies on beta emission from the P-32 isotope to destroy abnormal cells.
Product is approaching loss of exclusivity with minimal linked job openings, indicating a small, stable team focused on maintenance rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PHOSPHOCOL P32 offers a stable career in a niche, specialized radiopharmaceutical market with Curium Pharma, but limited growth or expansion prospects. This role suits professionals seeking specialized expertise in legacy products and palliative oncology rather than high-visibility commercial launches.
Worked on PHOSPHOCOL P32 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.